Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine

PURPOSE: There is no standard second-line regimen for malignant melanoma patients with disease progression after first-line chemotherapy, and platinum-alkylating agents combined with paclitaxel have shown modest efficacy. MATERIALS AND METHODS: We conducted a phase II, open-label, single-arm study t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Choong-kun, Jung, Minkyu, Choi, Hye Jin, Kim, Hye Ryun, Kim, Hyo Song, Roh, Mi Ryung, Ahn, Joong Bae, Chung, Hyun Cheol, Heo, Su Jin, Rha, Sun Young, Shin, Sang Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614200/
https://www.ncbi.nlm.nih.gov/pubmed/25687848
http://dx.doi.org/10.4143/crt.2014.261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614200/
https://www.ncbi.nlm.nih.gov/pubmed/25687848
http://dx.doi.org/10.4143/crt.2014.261

Ejemplares similares